Clinical Trial: Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933277) titled 'Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients' on April 03.

Brief Summary: This is an observational study aiming at collecting efficacy and safety data on the use of SVd outside clinical trials, for the treatment of adult patients with MM who have received 1-3 prior line of therapy.

A minimum of 159 patients is required. Overall study duration is estimated in 36 months.

Study Start Date: July, 2025

Study Type: OBSERVATIONAL

Condition: Multiple Myeloma

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

Publ...